Skip to Main Content

4,780

Views

4

CrossRef citations to date

0

Altmetric

Original Article: Clinical

Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study

Paula CramerDepartment I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital Cologne, Cologne, Germany; Correspondence[email protected]
View further author information

,

Graeme FraserJuravinski Cancer Centre, McMaster University, Hamilton, ON, Canada; View further author information

,

Rodrigo Santucci-SilvaHemomed Oncologia e Hematologia, IEP São Lucas, São Paulo, Brazil; View further author information

,

Sebastian GrosickiSilesian Medical University, Katowice, Poland; View further author information

,

Marie-Sarah DilhuydyHôpital Haut-Lévêque, Pessac, France; View further author information

,

Ann JanssensUniversitaire Ziekenhuizen Leuven, Leuven, Belgium; View further author information

,

Javier LoscertalesHematology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain; View further author information

,

Simon RulePlymouth University Medical School, Plymouth, UK; View further author information

,

Andre GoyJohn Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ, USA; View further author information

,

Shana TrainaJanssen Global Services, Raritan, NJ, USA; View further author information

,

Eric K. H. ChanJanssen Global Services, Raritan, NJ, USA; View further author information

,

Joris DielsJanssen EU HEMAR Statistics & Modelling, Beerse, Belgium; View further author information

,

Nishan SenguptaJanssen Global Oncology, Raritan, NJ, USA; View further author information

,

Michelle MahlerJanssen Global Services, Raritan, NJ, USA; View further author information

,

Mariya SalmanJanssen Global Services, Raritan, NJ, USA; View further author information

,

Angela HowesJanssen Research & Development, High Wycombe, UK; View further author information

&

Asher Chanan-KhanMayo Clinic Cancer Center, Jacksonville, FL, USAView further author information